Alltracel Pharmaceuticals Plc., ("Alltracel", or "the Company"), (AIM:AP.L), the
Healthcare Innovation Group focused on the Wound Care, Oral Care, Cardiovascular
Health and Cosmeceutical markets, is today pleased to announce it has begun a
six month co-funded product development programme with a leading global
commercialisation partner in the cosmeceuticals ingredient market. The
successful conclusion of the programme will lead to both parties entering into
an alliance to commercialise the PhytopeuticsTM range of dermal health solutions
in the global cosmeceutical market.
